Company intelligence / Profile preview

AI Merging Health

Paris, Île-de-France, Franceaimerginghealth.com ↗

Ownership: Private
Development stage: Preclinical

Overview

AI Merging Health developed an AI-powered platform to analyze healthcare databases and predict certain risks, enabling professionals to prevent negative outcomes. Their first product, Pregnanthee, uses deep learning to quantify the risk of fetal death or malformation. The company partnered with Babyprogress for childbirth risk assessment and aimed to expand into image recognition and broader clinical applications. No published clinical trial results are available as of the latest reports.

Therapeutic areas: Women's Health
Modalities: Device (AI-based risk prediction tool)Software/AlgorithmDeep learning algorithm
Industry: Digital Health Medical Devices

Partnerships

Babyprogress (for childbirth risk assessment support)

Beyond the preview

Go deeper on AI Merging Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AI Merging Health.

Explore the full profile